[1]BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2]陈钰锋,吴现瑞,吴小剑,等.免疫微环境在结直肠肿瘤中的临床预后价值[J].中华实验外科杂志,2012,29(02):350-351.
CHEN YF,WU XR,WU XJ,et al.Clinical prognostic value of immune microenvironment in colorectal tumors[J].Chin J Exp Surg,2012,29(02):350-351.
[3]BAGINSKA J,VIRY E,BERCHEM G,et al.Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxia[J].Proc Natl Acad Sci USA,2013,110(43):17450-17455.
[4]VIVIER E,UGOLINI S,BLAISE D,et al.Targeting natural killer cells and natural killer T cells in cancer[J].Nat Rev Immunol,2012,12(4):239-252.
[5] SMYTH MJ,CROWE NY,GODFREY DI. NK cells and NKT cells collaborate in host protection from methylcholanthrene-induced fibrosarcoma[J]. Int Immunol,2001,13(4):459-463.
[6]STREET SE,ZERAFA N,IEZZI M,et al. Host Perforin reduces tumor number but does not increase survival in oncogene-driven mammary adenocarcinoma[J].Cancer Res,2007,67(11):5454-5460.
[7]IMAI K,MATSUYAMA S,MIYAKE S,et al. Natural cytotoxic activity of peripheral-blood lymphocytes and cancer incidence:an 11-year follow-up study of a general population[J].Lancet,2000,356(9244):1795-1799.
[8]DAMBRAUSKAS Z,SVENSSON H,JOSHI M,et al.Expression of major histocompatibility complex class I-related chain A/B (MICA/B) in pancreatic carcinoma[J].Int J Oncol,2014,44(1):99-104.
[9] ULLENHAG GJ,MOZAFFARI F,BROBERG M,et al.Clinical and immune effects of lenalidomide in combination with gemcitabine in patients with advanced pancreatic cancer[J].PLoS One,2017,12(1):e0169736.
[10] PENG YP,ZHU Y,ZHANG JJ,et al.Comprehensive analysis of the percentage of surface receptors and cytotoxic granules positive natural killer cells in patients with pancreatic cancer,gastric cancer,and colorectal cancer[J].J Transl Med,2013,11:262.
[11]吴林峰,孙永吉,叶乐乐,等.结直肠癌组织浸润免疫细胞组成及特征[J].温州医科大学学报,2020,50(6):454-460.
WU LF,SUN YJ,YE LL,et al.Differences of immune cell composition between colorectal cancer and normal colorectal tissue[J].Journal of Wenzhou Medical University,2020,50(6):454-460.
[12]余咸静.结直肠癌细胞凋亡与其微环境中免疫细胞凋亡和浸润程度的关系[J].湖北科技学院学报(医学版),2021,35(01):21-24,93.
YU XJ.Relationship between apoptosis of colorectal cancer cells and apoptosis and infiltration degree of immune cells in the microenvironment[J].Journal of Hubei University of Science and Technology(Medical Sciences),2021,35(01):21-24,93.
[13]COCA S,PEREZ-PIQUERAS J,MARTINEZ D,et al.The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma[J].Cancer,1997,79(12):2320-2328.
[14]CAMUS M,TOSOLINI M,MLECNIK B,et al.Coordination of intratumoral immune reaction and human colorectal cancer recurrence[J].Cancer Res,2009,69(6):2685-2693.
[15]苏文.四万例癌症患者免疫细胞亚群检测及其临床意义[A].中国免疫学会.第十二届全国免疫学学术大会摘要汇编[C].中国免疫学会:中国免疫学会,2017:1.
SHU W.Detection of immune cell subsets in 40 000 cancer patients and its clinical significance[A].Chinese Society of Immunology.Compilation of abstracts of the 12th National Congress of Immunology[C].Chinese Society of Immunology:Chinese Society of Immunology,2017:1.
[16]CHAN JK,NG CS,HUI PK.A simple guide to the terminology and application of leucocyte monoclonal antibodies[J].Histopathology,1988,12(5):461-480.
[17]郭渊先,杜文龙,王佳,等.结直肠癌免疫逃逸机制研究的进展[J/OL].中国现代医学杂志,2021:1-10[2021-04-27].https://kns.cnki.net/kcms/detail/43.1225.R.20200803.0919.004.html.
GUO YX,DU WL,WANG J,et al.Advances in research on immune escape mechanism of colorectal cancer[J/OL].China Journal of Modern Medicine,2021:1-10[2021-04-27].https://kns.cnki.net/kcms/detail/43.1225.R.20200803.0919.004.html.
[18]黄秋萍,袁欢,王宜林,等.miRNA对自然杀伤细胞生长发育及功能的调控作用[J].分子诊断与治疗杂志,2019,11(01):63-67.
HUANG QP,YUAN H,WANG YL,et al.Regulation of miRNAs on the growth,development and function of natural killer cells[J].J Mol Diagn Ther,2019,11(01):63-67.
[19]王学富,田志刚.NK 细胞发育分化分子机制及其相关疾病研究进展[J].中国免疫学杂志,2015,31(5):577-584.
WANG XF,TIAN ZG.Molecular mechanisms of NK cell development and diseases associated with functional compromise of NK cells[J].Chinese Journal of Immunology,2015,31(5):577-584.
[20]STACEY E MILLS.Histology for pathologyists[M].4th ed.Philadelphia:Library of Congress Cataloging-in-Publication Data,2012:1-1299.
[21]付顺利,刘永军,张娜.肿瘤免疫治疗中NK细胞的激活策略及研究进展[J].生命的化学,2021,41(03):444-451.
FU SL,LIU YJ,ZHANG N.Activation strategy and research progress in NK cell based on tumor immunotherapy[J].Chemistry of Life,2021,41(03):444-451.
[22]孙玉琳,赵晓航.结直肠癌的分子分型及精准医学时代展望[J].中华结直肠疾病电子杂志,2018,7(05):412-419.
SUN YL,ZHAO XH.The molecular subtypes and their clinical relevance of colorectal cancer [J].Chin J Colorec Dis (Electronic Edition),2018,7(05):412-419.
[23]VALIPOUR B,VELAEI K,ABEDELAHI A,et al.NK cells:an attractive candidate for cancer therapy[J].J Cell Physiol,2019,234(11):19352-19365.
[24]KARED H,MARTELLI S,NG TP,et al.CD57 in human natural killer cells and T-lymphocytes[J].Cancer Immunol Immunother,2016,65(4):441-452.
[25] VAN DEN HOVE LE,VANDENBERGHE P,VAN GOOL SW,et al.Peripheral blood lymphocyte subset shifts in patients with untreated hematological tumors:evidence for systemic activation of the T cell compartment[J].Leukemia Research,1998,22(2):175-184.
[26]CHOI Y,KIM JW,NAM KH,et al.Systemic inflammation is associated with the density of immune cells in the tumor microenvironment of gastric cancer[J].Gastric Cancer,2017,20(4):602-611.